No Data
No Data
October 10 A-share Lightning Rod: tianfeng Securities: the company has no plans for merger and reorganization; changzhou almaden: shareholder Lin Jinkun intends to reduce shareholding by no more than 1.24%.
Hengshi Ophthalmology's shareholders Meixin Fund and Pengxin Fund intend to collectively reduce their holdings by no more than 0.83 million shares; Almaden's shareholder Lin Jinkun intends to reduce his shareholding by no more than 1.24%; Guangdong Dcenti Auto-Parts Stock's shareholder Taifeng International intends to reduce its shareholding by no more than 1%; ST Baili is suspected of violating disclosure regulations, and the CSRC has decided to initiate a case against the company and its controlling shareholder Wang Hairong; CSI All Share Investment Banking & Tianfeng Securities Co., Ltd. is not planning a merger or reorganization; *ST Zhongrun has terminated the private placement of stocks for the year 2022.
Hens Optometry (301103.SZ): Meixin Fund and Pengxin Fund plan to reduce their shareholdings by a total of no more than 0.83 million shares.
Gelonghui October 9th丨 Heshi Ophthalmology (301103.SZ) announced that Meixin Fund, Pengxin Fund plans to reduce the company's shares by a total of no more than 0.83 million shares through centralized auction trading on the stock exchange fifteen trading days after the disclosure date of this announcement within three months (i.e. from October 31, 2024 to January 30, 2025), accounting for 0.53% of the total share capital after excluding the shares in the repurchase special securities account.
Subdued Growth No Barrier To Liaoning He Eye Hospital Group Co., LTD. (SZSE:301103) With Shares Advancing 26%
Ho\'s Ophthalmology: 2024 Semi-Annual Report Summary
Ho\'s Ophthalmology: Semi-Annual Report 2024
Huan Shi Ophthalmology (301103.SZ) released its performance for the first half of the year, with a net income of 24.064 million yuan, a decrease of 69.29% year-on-year.
He Shi Eye Hospital (301103.SZ) released its 2024 interim report, reporting a revenue of 5... for the reporting period...
No Data
No Data